Price
No data yet.
Social Signal Score
Revenue
$7.43M-9.47%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Albert David Friesen
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 23
- Beta
- 1.04
- Country
- CA
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -2.70
Financials
Revenue
$7.43M-9.5%Net Income
$-1.43M-171.3%EBITDA
$-577.0K-120.0%Free Cash Flow
$386.0K+30.5%EPS (diluted)
$-0.14-216.7%Shares Outstanding (diluted)
10.20M-38.6%Operating Expenses
$4.55MCash & Debt
$1.83MReturn of Capital
$0.00Revenue by Segment (annual)
$8.0KQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $28.83M | $-7.09M | $-0.68 |
| 2024 | $21.91M | $-1.04M | $-0.10 |
| 2023 | $21.69M | $-922.0K | $-0.09 |
| 2022 | $23.07M | $1.36M | $0.13 |
| 2021 | $21.74M | $-727.0K | $-0.07 |
| 2020 | $11.61M | $-6.89M | $-0.65 |
| 2019 | $20.17M | $-19.79M | $-1.32 |
| 2018 | $29.11M | $3.93M | $0.25 |
| 2017 | $27.13M | $43.42M | $2.78 |
| 2016 | $37.78M | $27.66M | $1.80 |
| 2015 | $22.08M | $1.67M | $0.12 |
| 2014 | $5.05M | $-1.64M | $-0.13 |
| 2013 | $2.60M | $-2.57M | $-0.21 |
| 2012 | $4.80M | $23.39M | $1.99 |
Valuation
MCUJFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+21.21%Social Signal Score
Mentions (4)
- Newsaccessnewswire.com·4d ago·Neutral
Medicure Announces Grant of Stock Options WINNIPEG, MB / ACCESS Newswire / October 1, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced the granting of stock options (the "Options") to certain directors, officers, employees and consultants of the Company to purchase a total of 150,000 common sh…
View source ↗ - Newsaccessnewswire.com·7d ago·Negative
…ollment in Its MEND-PNPO Phase 3 Clinical Trial WINNIPEG, MB / ACCESS Newswire / September 28, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced the completion of patient enrollment in the MEND-PNPO Phase 3 study (ClinicalTrials.gov NCT04706013), a pivotal trial evaluating MC-1 for the treatmen…
View source ↗ - Newsaccessnewswire.com·27d ago·Neutral
…line Data at the 16th European Epilepsy Congress WINNIPEG, MB / ACCESS Newswire / September 8, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that the design, rationale and baseline data from its MEND-PNPO Phase 3 study (ClinicalTrials.gov NCT04706013) are being presented at the 16th Europea…
View source ↗ - Newsaccessnewswire.com·52d ago·Negative
…2026 and Schedules August 17, 2026 Conference Call WINNIPEG, MB / ACCESS Newswire / August 14, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended June 30, 2026 and will have a conference call to present the Financial Results on August 17, 2026 at …
View source ↗
Earnings
Thu, Nov 19(in 6 weeks)
Consensus estimate $-0.02 per share
Typical surprise +5.0% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 14$-0.10 vs $-0.05miss
- Thu, May 21$-0.03 vs $-0.03beat
- Wed, Nov 19$-0.09 vs $-0.09beat
- Wed, Aug 20$-0.06 vs $-0.07beat
- Wed, May 21$-0.05 vs $-0.06beat
- Mon, Nov 25$0.05 vs $-0.05beat
Estimates and results for MCUJF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in MCUJF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.